Clinical Trial Update: Pyrazoloacridine in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 clinical trial evaluating pyrazoloacridine in women with metastatic breast cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrazoloacridine (pyrazoloacridine)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED